UK

Archimedes Pharma UK Limited markets a portfolio of products to specialist prescribers in the areas of pain, oncology, critical care and Parkinson’s disease. This expertise underpins the commercial potential for the recent UK launch of the transformational product for Archimedes, PecFent^® (fentanyl pectin nasal spray), an innovative nasal spray aimed at managing breakthrough pain in cancer.

Products marketed in the UK include:

• PecFent^® (fentanyl pectin nasal spray). View the SmPC
• Gliadel^® implant (carmustine). View the SmPC
• Zomorph^® capsule (morphine sulphate). View the SmPC
• Apomorphine injection (apomorphine HCl). View the SmPC
• Pabrinex^® injection (high potency formulation of vitamins B and C). View the SmPC